Search  in | Advanced
   Print  
Government/Advisory Meetings


IN THIS SECTION

ANALYSIS
Analysis of FDA Guidance Documents to Promote Transparency of Advisory Committees

Analysis of Draft Guidance on FDA Conflict of Interest Policy

QUICK LINKS
Ask the FDA Transcripts

Government/Regulatory Affairs
 
AABB participates in or hosts meetings in conjunction with the federal government in its role representing the interests of the transfusion medicine and cellular therapies communities. For more detail about specific meetings, click on a link below.

Advisory Committee on Blood Safety and Availability

Blood Products Advisory Committee

Cellular, Tissue and Gene Therapies Advisory Committee

Transmissible Spongiform Encephalopathies Advisory Committee

Public Meetings

FDA Liaison Meetings
Blood and Blood Components
- Cellular Therapies

Last modified on 8/27/2008 4:11:57 PM
What's New!
Call for AABB Award Nominations
Details
2008 AABB Annual Meeting & TXPO Online
Details
AABB Weekly Report - October 3, 2008
Details
AABB Announces 2008 Award and Scholarship Recipients
Details
The National Blood Foundation (NBF) Announces Recipients of the 2008 NBF Scientific Research Grants
Details
Association Bulletin #08-04 - Strategies to Reduce Adverse Reactions and Injuries in Younger Donors
Details
Summary of Draft Comments to be Submitted to TJC on Blood Management Performance Measures
Details
Significant Changes to the Standards for Cellular Therapy Product Services, 3rd edition
Details
First Ever National Biovigilance Network in the U.S. Reaches $1 Million in Funding, Prepares for Fall Pilot Launch
Details
2008 West Nile Virus Biovigilance Network
Details
List of AABB-Accredited Facilities with Approved Variances for ISBT 128
Details
Instructions on Applying for an AABB Variance
Details